Showing 21 - 35 results of 35 for search '"pharmacoeconomics"', query time: 0.08s Refine Results
  1. 21

    Tackling Extended Hospital Stays in Patients with Acute Bacterial Skin and Skin Structure Infections by Gavin Barlow, Michael Wilke, Guillaume Béraud

    Published 2022-09-01
    “… Hospitalisation rates for acute bacterial skin and skin structure infection (ABSSSI) are rising and represent a large pharmacoeconomic burden as treatment may involve an extended number of days of antibiotic therapy. …”
    Get full text
    Article
  2. 22

    Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hos... by Laura Puzniak, Ryan Dillon, Thomas Lodise

    Published 2023-01-01
    “…We aimed to determine if available evidence from a previously conducted systematic literature review was sufficient to conduct a robust network meta-analysis (NMA) using the International Society for Pharmacoeconomics and Outcomes Research Good Practice Task Force NMA study questionnaire to evaluate suitability, relevance, and credibility of available randomized-controlled trials (RCT) of antibacterial therapies for treatment of patients with hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP). …”
    Get full text
    Article
  3. 23

    Translation and Cultural Adaptation of the ISTH-Bleeding Assessment Tool to European Portuguese by Diana Carneiro-Leão, Sofia Teixeira, Rita Queirós Pereira, Teresa Mota, Manuela Lopes, Susana Nobre-Fernandes, Fernando Araújo

    Published 2025-02-01
    “…Methods: The translation and cultural adaptation were based on the International Society for Pharmacoeconomics and Outcomes Research Guidelines and initiated after obtaining permission from the authors. …”
    Get full text
    Article
  4. 24
  5. 25

    Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned surv... by Gang Fang, Zhipeng Pi, Yiping An, Xinxin Cao, Wei Li, Wei Li, Xiangjun Zhu, Jinxi Ding, Jinxi Ding

    Published 2025-01-01
    “…However, the comparison of their efficacy and pharmacoeconomics profiles remains limited. This study aims to evaluate the cost-effectiveness of gumarontinib versus savolitinib for the treatment of METex14 skipping NSCLC in China.MethodsA 3-state partitioned survival model (PSM) was developed with lifetime horizon from the perspective of Chinese healthcare system. …”
    Get full text
    Article
  6. 26
  7. 27

    Lasater clinical judgment rubric in nursing education: a Turkish validity and reliability study by Esra Sezer, Hilal Yıldız Çelik, Ükke Karabacak, Kathie Lasater

    Published 2025-01-01
    “…The language validity of the rubric was performed according to the 10-step translation and cultural adaptation guide of the International Society for Pharmacoeconomics and Outcomes Research; expert opinions were obtained for content validity. …”
    Get full text
    Article
  8. 28
  9. 29

    Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review by Chao Wang, Yunzhuo Dong, Peng Men, Ruixia Zhang, Ying Xiao, Yishan Bu, Yinpeng Qin, Xinran Zhang, Qianqian Dou, Yiheng Yang, Huier Gao, Yi Zhang

    Published 2025-01-01
    “…A literature search was conducted across multiple databases, including PubMed, Embase, Wanfang, CNKI, Weipu database, the Cochrane Library, the Centre for Reviews and Dissemination (CRD) database, International Network of Agencies for Health Technology Assessment (INAHTA) and Canada’s Drug Agency (CDA-AMC), International Society for Pharmacoeconomics and Outcomes Research (ISPOR), National Institute For Health and Care Excellence (NICE), Institute For Clinical And Economic Review (ICER), Grey Literature Database and Grey Net International. …”
    Get full text
    Article
  10. 30
  11. 31

    THE STUDY OF PREVALENCE OF HYPERSENSITIVITY TO Β-LACTAM ANTIBIOTICS AMONG THE POPULATION OF UKRAINE by A.V. Lavrenko, I.P. Kaidashev

    Published 2018-10-01
    “…The aim of this research was to determine the prevalence of hypersensitivity to β-lactam antibiotics among the population, by examining anamnestic data and conducting allergological examination to increase the safety of antibiotic therapy and improve the pharmacoeconomic profile of treatment.…”
    Get full text
    Article
  12. 32

    Cost-effectiveness and economic analysis of antibiotics: a comprehensive study utilizing ICER and ACER metrics by Prajnashree Acharya, Someshwar S. Karabasanawar, Anurag R. Sattigeri, Vasudev P. Pai, Laxmi B. Totar, Sanatkumar Bharamu Nyamagoud

    Published 2024-12-01
    “…Aims and Objectives: The study aimed to evaluate the pharmacoeconomic impact of antibiotic treatments using CEA in a healthcare setting, focusing on identifying cost-effective antibiotics and promoting rational prescribing practices. …”
    Get full text
    Article
  13. 33

    Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands. by Bart Slob, Tanja Fens, Maaike Weersma, Maarten Postma, Cornelis Boersma, Lisa de Jong

    Published 2024-01-01
    “…Discounting was done according to the Dutch pharmacoeconomic guidelines. The incremental cost-effectiveness ratio (ICER) was compared to a willingness-to-pay threshold of €50,000/QALY. …”
    Get full text
    Article
  14. 34

    PHARMACEUTICAL CARE OF ACNE PATIENTS USING SYSTEMIC RETINOIDS by Yuliya Nastyukha, Andriy Zimenkovsky, Diana Klapko

    Published 2023-12-01
    “…The following methods were used: systematic approach, bibliographic, questionnaire survey, statistical, pharmacoeconomic assessment. The objects of the study: relevant information sources; current standards of pharmacotherapy, instructions for medical use of isotretinoin of the State Register of Medicines of Ukraine (n=4), 14th edition of the State Drug Formulary; questionnaires of acne patients who use systemic retinoids (n=53); pharmacy quotes for isotretinoin drugs and laboratory quotes for liver biopsy and lipid testing. …”
    Get full text
    Article
  15. 35